Mealey's (March 11, 2022, 8:28 AM EST) -- BROOKLYN, N.Y. — A federal judge in New York on Feb. 23 significantly trimmed shareholder claims in a securities class action against a diagnostic testing company, certain of its officers and directors and underwriters of the company’s May 2020 stock offering, ruling that although lead plaintiffs have sufficiently alleged that the underwriter defendants issued material misrepresentations relating to the company’s COVID-19 test in offering documents, they have failed to properly plead the elements of their federal securities law claims against any other defendant....